An Indiana CDMO with big-name clients sets up plans for lentiviral production site

Josh Sullivan

An Indiana CDMO focused on gene therapy is cashing in on the industry’s hot streak and unveiling a master plan for a 75,000-square-foot lentiviral vector …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

An Indiana CDMO with big-name clients sets up plans for lentiviral production site

Josh Sullivan

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Exclusive: Kennedy picks for vaccine advisory board were paid experts against Merck in civil cases

RFK Jr. names eight new ACIP members, including popular vaccine critic Robert Malone

BioNTech to acquire CureVac in all-stock deal valued at $1.25B

Insmed aims to raise $750M in one of the largest stock offerings this year

ADC Therapeutics reveals layoffs, $100M PIPE; Third Harmonic seeks buyer for asset

McKesson leads the charge in revolutionizing precision oncology in community practices

An In­di­ana CD­MO with big-name clients sets up plans for lentivi­ral pro­duc­tion site

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

An Indiana CDMO with big-name clients sets up plans for lentiviral production site